Section Arrow
PTCT.NASDAQ
- PTC Therapeutics
Quotes are at least 15-min delayed:2025/06/04 14:58 EDT
Last
 51.34
+0.65 (+1.28%)
Day High 
51.57 
Prev. Close
50.69 
1-M High
51.375 
Volume 
823.68K 
Bid
51.32
Ask
51.37
Day Low
50.43 
Open
51.23 
1-M Low
35.95 
Market Cap 
4.02B 
Currency USD 
P/E 7.79 
%Yield -- 
10-SMA 47.69 
20-SMA 45.9 
50-SMA 47.22 
52-W High 58.38 
52-W Low 28.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
6.51/-1.58
Enterprise Value
6.22B
Balance Sheet
Book Value Per Share
-2.34
Cash Flow
Cash Flow Yield
0.17
Income Statement
Total Revenue
806.78M
Operating Revenue Per Share
10.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CLRBCellectar Biosciences0.5053+0.2277+82.02%-- 
NCNANuCana plc0.0445-0.0153-25.59%-- 
RXRXRecursion Pharmaceuticals4.855+0.465+10.59%-- 
HOTHHoth Therapeutics1.432+0.5122+55.69%-- 
SGMTSagimet Biosciences4.075+0.445+12.26%-- 
Quotes are at least 15-min delayed:2025/06/04 14:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.